000			01928 a2200541 4500
005			20250515000444.0
264		0	_c20060119
008			200601s 0 0 eng d
022			_a0026-895X
024	7		_a10.1124/mol.105.012716 _2doi
040			_aNLM _beng _cNLM
100	1		_aKarnitz, Larry M
245	0	0	_aGemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. _h[electronic resource]
260			_bMolecular pharmacology _cDec 2005
300			_a1636-44 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aCell Cycle Proteins _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aCheckpoint Kinase 2
650	0	4	_aCytarabine _xpharmacology
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHumans
650	0	4	_aProtein Kinases _xmetabolism
650	0	4	_aProtein Serine-Threonine Kinases _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Suppressor Proteins _xmetabolism
650	0	4	_aGemcitabine
700	1		_aFlatten, Karen S
700	1		_aWagner, Jill M
700	1		_aLoegering, David
700	1		_aHackbarth, Jennifer S
700	1		_aArlander, Sonnet J H
700	1		_aVroman, Benjamin T
700	1		_aThomas, M Bijoy
700	1		_aBaek, Yong-Un
700	1		_aHopkins, Kevin M
700	1		_aLieberman, Howard B
700	1		_aChen, Junjie
700	1		_aCliby, William A
700	1		_aKaufmann, Scott H
773	0		_tMolecular pharmacology _gvol. 68 _gno. 6 _gp. 1636-44
856	4	0	_uhttps://doi.org/10.1124/mol.105.012716 _zAvailable from publisher's website
999			_c15763243 _d15763243